IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Monocytes as Targets for Cancer Therapies

Monocytes as Targets for Cancer Therapies
View Sample PDF
Author(s): Astha Singh (National Institute of Pathology, New Delhi, India)
Copyright: 2021
Pages: 7
Source title: Handbook of Research on Advancements in Cancer Therapeutics
Source Author(s)/Editor(s): Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India) and Saurabh Verma (National Institute of Pathology, India)
DOI: 10.4018/978-1-7998-6530-8.ch027

Purchase

View Monocytes as Targets for Cancer Therapies on the publisher's website for pricing and purchasing information.

Abstract

The importance of monocytes in modulating the lymphocyte dependent tumor necrosis is a target for cancer therapeutics. Monocytes produce a plethora of chemokine receptors. Lymphocyte to monocyte ratio is one of the negative factors in cancer patients. It is being targeted for treatment of abnormal lymphocytopenia and monocytosis in untreatable metastatic cancer patients. The aim of the chapter is to throw light on the circadian and psychological factors that modulate the progression of cancer and identify novel targets for controlling transformation of preneoplasms to neoplasms, invasiveness, and metastasis.

Related Content

Mayuree Tangkiatkumjai. © 2022. 12 pages.
Dawn-Marie Walker, Mayuree Tangkiatkumjai. © 2022. 13 pages.
G. Ramadhas, A.S. Suman Sankar, N.V. Sugathan. © 2022. 17 pages.
Aashaq Hussain Bhat, Himani Goyal Sharma. © 2022. 19 pages.
Kiran Mustafa, Javaria Kanwal, Sara Musaddiq, Samia Khakwani. © 2022. 14 pages.
Sreekumari Kurissery, Leah Katherine Shaw, Nandakumar Kanavillil. © 2022. 25 pages.
Ankita Gautam. © 2022. 18 pages.
Body Bottom